Your browser doesn't support javascript.
loading
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
Shashar, Moshe; Nacasch, Naomi; Grupper, Ayelet; Benchetrit, Sydney; Halperin, Tamar; Erez, Daniel; Rozenberg, Ilan; Shitrit, Pnina; Sela, Yaron; Wand, Ori; Cohen-Hagai, Keren.
Afiliação
  • Shashar M; Department of Nephrology and Hypertension, Laniado Hospital, Netanya, Israel.
  • Nacasch N; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
  • Grupper A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Benchetrit S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Halperin T; Department of Nephrology and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Erez D; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
  • Rozenberg I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shitrit P; Laboratory for HIV Diagnosis, The HIV Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Sela Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wand O; Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel.
  • Cohen-Hagai K; Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
Am J Nephrol ; 53(2-3): 207-214, 2022.
Article em En | MEDLINE | ID: mdl-35172312

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Am J Nephrol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Am J Nephrol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel